bioAffinity Technologies Inc

For the period ended Apr 15, 2024. Filed Apr 15, 2024.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Apr 15, 2024 · Filed Apr 15, 2024

Use the contents to explore the available documents and sections.

BIAF$2.72+4.4%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Compensation Programs

We have historically compensated our employees with restricted stock awards and/or stock options in addition to salaries and other forms of cash compensation.

Our non-employee directors receive compensation for their service as directors and members of committees of the Board, which has historically consisted of cash and restricted stock awards.

If approved by the stockholders, the Charter Amendment will enable the Company to continue to compensate its employees and directors in equity awards under its compensation programs.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.